RAYDIAX Company Market Research Report

Company Overview

Name: RAYDIAX GmbH

Mission: To increase the quality of everyday minimally invasive interventions by providing the world's first therapy-assistance CT system.

Founded: 2012 as a university spin-off.

Key People:

• Thomas Hoffmann, CEO

• Tim Pfeiffer, CTO

• Roy Rothenberg, CFO

• Benjamin Fritsch, Head of Hardware

• Robert Frysch, Head of Software

• André Mewes, Head of Software

• Sebastian Gugel, Head of Medical Affairs

• Several other team members in hardware engineering, mechanical engineering, business development, and medical affairs.

Headquarters: Otto-Hahn-Straße 2, 39106 Magdeburg, Germany.

Number of Employees: No information is available.

Revenue: No information is available.

Known For: RAYDIAX is known for their innovative imaging device in the high-tech radiology environment, specifically their therapy-assistance CT system known as TACT.

Products

RAYDIAX TACT

• Description: Combines high-quality and fast 3D multislice CT imaging with large-area 2D angiography. It is designed for minimally invasive interventions.

• Key Features:

• Hybrid Imaging: Expands the treatable patient spectrum and supports fast modality switching.

• Dose Optimization: Offers new methods of image acquisition with substantial dose optimization.

• Interventional Workflow: Features include a 1-meter free inner diameter, free-floating table, and off-center positioning to enhance procedural safety and efficiency.

Recent Developments

Recent Partnerships and Developments:

• September 2024: Sponsored and participated in the VCBM 2024 and was recognized at the Startup Germany Summit.

• February 2024: Discussed as a sparring partner for new start-up initiatives, resulting from scientific transfer from the Forschungscampus STIMULATE.

• December 2023: Long-term partnership institutionalized with the STIMULATE research campus.

• October 2023: Raised €3.5 million for pre-clinical prototype and business growth.

New Features and Product Launches:

• No new product launches recorded, but ongoing development and recognition highlight the company's active role in innovation within the field.

Partnerships:

• Long-term partnership with Forschungscampus STIMULATE reinforced to deepen clinical and technical research.

• Presentation and acknowledgment at events like the STIMULATE-Retreat and meetings with prominent figures such as Olaf Scholz and local political leaders to strengthen economic and strategic collaborations.

This report is based solely on the data presented and no additional commentary has been made.